阿里健康：医药电商增长强劲

Core Viewpoint - Alibaba Health is expected to achieve significant revenue and profit growth in the upcoming fiscal year, with forecasts indicating a revenue range of 34.594 to 35.296 billion yuan, representing a year-on-year growth of 13.1% to 15.4% [1][3]. Financial Performance Forecast - Projected revenue for Alibaba Health is between 34.594 billion and 35.296 billion yuan, with a year-on-year growth of 13.1% to 15.4% [1][3]. - Expected net profit is forecasted to be between 2.003 billion and 2.286 billion yuan, showing a year-on-year increase of 39.8% to 59.6% [1][3]. - Adjusted net profit is anticipated to range from 2.003 billion to 2.493 billion yuan, with a growth rate of 2.7% to 27.9% [1][3]. Business Segments - In the pharmaceutical self-operated and e-commerce platform segment, Alibaba Health has become the largest online B2C healthcare retail platform in China, with over 300 million annual active consumers and a year-on-year SKU growth of over 24% to 97 million [4][5]. - The company is advancing the application of large models in the pharmaceutical e-commerce sector, enhancing efficiency in search optimization, smart supply chains, product operations, and intelligent customer service, thereby creating incremental GMV [5]. - The integration of AI and specialized services is forming a traffic closed loop within Alibaba's ecosystem, with monthly active users of the Ant Group's app exceeding 15 million and the Qianwen app surpassing 200 million, which could enhance transaction efficiency and customer retention [4][5].